Cargando…

Association of Prescription Abandonment with Cost Share for High-Cost Specialty Pharmacy Medications

BACKGROUND: In 2008, specialty medications accounted for 15.1% of total pharmacy benefit medication spending, and per member expenditures have increased by 11.1% annually from 2004 to 2008 within a commercially insured population of 8 million members. Insurers face increasing pressure to control spe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gleason, Patrick, Starner, Catherine I., Gunderson, Brent W., Schafer, Jeremy A., Sarran, H. Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441203/ https://www.ncbi.nlm.nih.gov/pubmed/19803554 http://dx.doi.org/10.18553/jmcp.2009.15.8.648

Ejemplares similares

Generic Drug Discount Programs: Are Prescriptions Being Submitted for Pharmacy Benefit Adjudication?
por: Tungol, Alexandra, et al.
Publicado: (2012)

Health Plan Utilization and Costs of Specialty Drugs Within 4 Chronic Conditions
por: Gleason, Patrick P., et al.
Publicado: (2013)

Utilization, Cost Trends, and Member Cost - Share for Self-Injectable Multiple Sclerosis Drugs-Pharmacy and Medical Benefit Spending From 2004 Through 2007
por: Kunze, April M., et al.
Publicado: (2007)

Drug super spender tsunami: An integrated medical and pharmacy benefits assessment
por: Starner, Catherine I, et al.
Publicado: (2022)

Pharmacy Students' Views of Managed Care Pharmacy and PBMs: Should There Be More Exposure to Managed Care in the Pharmacy Curriculum?
por: Pittenger, Amy L., et al.
Publicado: (2010)

An Ambulatory Care Clinic and Community Pharmacy Collaboration to Address Prescription Abandonment
por: Gaborcik, Joshua W., et al.
Publicado: (2019)

Specialty Pharmacy Cost Management Strategies of Private Health Care Payers
por: Stern, Debbi, et al.
Publicado: (2006)

Association of a Controlled Substance Scoring Algorithm with Health Care Costs and Hospitalizations: A Cohort Study
por: Starner, Catherine I., et al.
Publicado: (2016)

Real-world outcomes and direct care cost before and after elexacaftor/tezacaftor/ivacaftor initiation in commercially insured members with cystic fibrosis
por: Marshall, Landon Z, et al.
Publicado: (2023)

Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy
por: Lankford, Cory, et al.
Publicado: (2021)

Estimated Cost Savings Associated with the Transfer of Office-Administered Specialty Pharmaceuticals to a Specialty Pharmacy Provider in a Medical Injectable Drug Program
por: Baldini, Christopher
Publicado: (2011)

Community Pharmacy and Mail Order Cost and Utilization for 90-Day Maintenance Medication Prescriptions
por: Khandelwal, Nikhil, et al.
Publicado: (2012)

Price Increases and New Drugs Drive Increased Expenditures for Multiple Sclerosis
por: Schafer, Jeremy A., et al.
Publicado: (2010)

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events
por: Starner, Catherine I., et al.
Publicado: (2008)

Member Satisfaction Related to Self-Reported Cost Share and Difficulty in Obtaining Prescription Drugs in a University Pharmacy Benefit Plan
por: Nau, David P., et al.
Publicado: (2007)

The Emergence of Specialty Pharmacy
por: Vanscoy, Gordon J.
Publicado: (2020)

The Reemergence of Specialty Pharmacy
por: Vanscoy, Gannon, et al.
Publicado: (2020)

PHARMACY DEDUCTIBLES CAN COMPLICATE THE RELATIONSHIP BETWEEN MEASURES OF PATIENT COST SHARING AND MEDICATION ADHERENCE
por: Kogut, Stephen J, et al.
Publicado: (2023)

Adherence of patients to oral oncolytic and neurologic specialty medications provided by a specialty pharmacy
por: Bhusal, Binita, et al.
Publicado: (2019)

Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
por: Park, Haesuk, et al.
Publicado: (2015)

The association between cost sharing, prior authorization, and specialty drug utilization: A systematic review
por: Ismail, Wesam W, et al.
Publicado: (2023)

The Future of Prescription Drug Cost-Sharing: Real Progress or Dropped Opportunity?
por: Fairman, Kathleen A.
Publicado: (2008)

Medical Costs and Health Care Utilization Among Self-Insured Members with Carve-In Versus Carve-Out Pharmacy Benefits
por: Smith, Julia J., et al.
Publicado: (2020)

Pharmacy Students Teaching Prescribers Strategies to Lower Prescription Drug Costs for Underserved Patients
por: Stebbins, Marilyn R., et al.
Publicado: (2013)

An Integrated Health-System Specialty Pharmacy Model for Coordinating Transitions of Care: Specialty Medication Challenges and Specialty Pharmacist Opportunities
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Cholinesterase Inhibitor Utilization Patterns: Just Because It Can Be Counted Does Not Mean It Counts
por: Starner, Catherine I., et al.
Publicado: (2008)

Management of specialty drugs, specialty pharmacies and biosimilars in the United States
por: Brook, Richard A., et al.
Publicado: (2019)

Relationship of the Use and Costs of Physician Office Visits and Prescription Drugs to Travel Distance and Increases in Member Cost Share
por: Cecil, William T., et al.
Publicado: (2006)

Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update
por: Bowlus, Christopher L., et al.
Publicado: (2016)

The Effect of Changes in Cost Sharing on the Consumption of Prescription and Over-the-Counter Medicines in Catalonia
por: Martínez-Jiménez, Mario, et al.
Publicado: (2021)

A Comparison of Costs of Medicare Part D Prescriptions Dispensed at Retail and Mail Order Pharmacies
por: Carroll, Norman V.
Publicado: (2014)

Analysis of Costs to Dispense Prescriptions in Independently Owned, Closed-Door Long-Term Care Pharmacies
por: Carroll, Norman V., et al.
Publicado: (2014)

Relationship of the Magnitude of Member Cost-Share and Medication Persistence With Newly Initiated Renin Angiotensin System Blockers
por: Zhang, Dongmu, et al.
Publicado: (2007)

What does it cost to redispense unused medications in the pharmacy? A micro-costing study
por: Bekker, Charlotte L., et al.
Publicado: (2019)

Managing Specialty Medication Services Through a Specialty Pharmacy Program: The Case of Oral Renal Transplant Immunosuppressant Medications
por: Tschida, Suzanne, et al.
Publicado: (2013)

Medical costs, Cesarean delivery rates, and length of stay in specialty hospitals vs. non-specialty hospitals in South Korea
por: Kim, Seung Ju, et al.
Publicado: (2017)

Best Practices in Specialty Pharmacy Management
por: Patterson, Courtney J.
Publicado: (2013)

Predicting the Physician's Specialty Using a Medical Prescription Database
por: Akhlaghi, Mahboube, et al.
Publicado: (2022)

Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies
por: Academia, Emmeline C, et al.
Publicado: (2021)

Association between health system specialty pharmacy use and health care costs among national sample of Medicare Advantage beneficiaries
por: Hellems, Sarah S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uqerk6jrd3ulim639pjrophn8r